


Gamma Vaccines Pty Revenue
Biotechnology Research • PO Box 4435 Manuka, Canberra, Australia • 1-10 Employees
Gamma Vaccines Pty revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at Gamma Vaccines Pty
Hugh Crawford
Director
Company overview
| Headquarters | PO Box 4435 Manuka, Canberra, ACT 2603, AU |
| Phone number | +61420942824 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2009 |
| Employees | 1-10 |
| Socials |
About Gamma Vaccines Pty
Gamma Vaccines was established to solve one of the great challenges in infectious disease - the development of a “universal” cross-protective influenza virus vaccine. Its product - Gamma-Flu® - is a uniquely inactivated whole-virus vaccine that is expected to provide broad-spectrum immunity to all seasonal and pandemic influenza A viruses. In addition, Gamma Vaccines has a pipeline of vaccine opportunities aimed at preventing other globally important viral diseases. The company is also seeking opportunities to exploit its technology platform for veterinary applications, including the production of novel avian influenza vaccines for preventing bird flu outbreaks in poultry. The company upholds the principles of Global Health and will seek to ensure that its improved vaccines are available for both developed and developing country markets – with the aim of reducing global morbidity and mortality from infectious diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Gamma Vaccines Pty has never raised funding before.
Frequently asked questions
4.8
40,000 users



